Immune checkpoint inhibitors in prostate cancer: Current and future practice

touchEXPERT OPINIONS for touchONCOLOGY

Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions.

The experts

• Prof. Karim Fizazi - Gustave Roussy, Villejuif, France
• Dr Sandy Srinivas - Stanford University, Stanford, CA, USA
• Prof. Johann de Bono - The Institute of Cancer Research, London, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Merck Sharp & Dohme Corp. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/icis-prostate-cancer/